Blue Earth Diagnostics
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.0Mgeneral payments (2019-2025)
$24Kresearch payments (2019-2025)
7,465clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Christopher Cutie | Boston, MA | Urology | $227,222.85 |
| Don Yoo | Warwick, RI | Diagnostic Radiology | $174,182.63 |
| Katherine Zukotynski | Boston, MA | Nuclear Radiology | $168,475.00 |
| Giuseppe Esposito | Washington, DC | Nuclear Medicine | $126,226.51 |
| Phillip Kuo | Duarte, CA | Diagnostic Radiology | $86,844.53 |
| Gary Ulaner | Los Angeles, CA | Diagnostic Radiology | $79,791.96 |
| Sean Collins | Washington, DC | Radiation Oncology | $79,304.88 |
| Matthew Kay | Tucson, AZ | Diagnostic Radiology | $76,916.13 |
| Priya Kumthekar | Chicago, IL | Hematology & Oncology | $76,834.53 |
| John Sampson | Aurora, CO | Neurological Surgery | $74,402.50 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.